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2.Abstract 
  The importance of the role played by bacteria in the pathogenesis of pulpal and 
apical disease has been established. One of the characteristics of apical periodontitis 
is apical bone resorption, which is due to apical immune response to bacterial 
infection. Recently, novel bacterial complex lipids have been reported to be 
inflammatory activators. These novel bacterial lipids stimulate prostaglandin E2, IL-6, 
and TNF-α secretion, inhibit osteoblast differentiation and function, and induce 
osteoclast formation. Also the bacterial lipids were observed in infected or necrotic 
root canals. A recently discovered  bacterial lipid that contains serine was observed to 
produce the effects described above but also has been shown to mediated these effects 
through engagement of Toll-like receptor 2.  These new findings imply that bacterial 
lipids could be important virulent factors that cause apical bone resorption.  The 
purpose of this study was to investigate whether treatment of the serine bacterial lipid 
with calcium hydroxide alters its biological action as measured by the mouse 
macrophage cell secretion of TNF-α. Calcium hydroxide-mediated alteration of 
biological properties of the bacterial lipids may be another important reason for the 
beneficial effects obtained with calcium hydroxide use in clinical endodontics.  In the 
present investigation, mouse macrophages were stimulated with bacterial lipids with 
or without calcium hydroxide treatment. The cell culture supernatants were analyzed 
for TNF-α1 by ELISA. Untreated cells cultured without lipids served as negative 
controls. Cells cultured with LPS served as positive controls. We found that anti-
mouse TLR2 antibody significantly reduced the effect of total lipid. Also, total lipid 
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significantly promoted the release of TNF-alpha from macrophages.  Calcium 
hydroxide treatment significantly reduced the effect of the serum lipid effect on the 
release of TNF-alpha.  This study demonstrated that serine bacterial lipid of P. 
gingivalis could participate in apical bone resorption associated with pulpal disease. It 
also demonstrates the effect of calcium hydroxide on this lipid.  Based on these 
findings, the rationale for use of calcium hydroxide in root canal therapy can be 
expanded to include the hydrolysis of bacterial lipids that are known to promote 
immune cell activation and bone resorption.  These results also provide an additional 
argument to perform two-visit non-surgical root canal treatment using calcium 
hydroxide as an intracanal medicament for better disinfection of the necrotic root 
canals.  
 
 
 
 
 
 
3.Review of Literature 
3.1.Physiology of the pulp 
The dental pulp is an organ enclosed in the lumen of the tooth, surrounded by 
dentin. Its health represents the vitality of the tooth. The pulpal tissue is mainly  
composed of connective tissue that contains blood vessels, ground substances, 
interstitial fluid, odontoblasts, fibroblasts and other components. The pulpal tissue is a 
unique organ because the soft tissues are enclosed inside hard dentin and enamel 
leading to a low compliance environment. In addition, the pulp also has an 
exceptionally responsive sensory system due to its rich supply of sensory fibers [1]. 
Furthermore, the pulp contains cells involved in producing inflammatory responses to 
noxious stimuli including but not limited to dendritic antigen presenting cells [2-5].  
Inflammatory reactions usually result in vasodilation, edema and increased volume of 
the inflamed tissue, the limited pulp space leads to an increased tissue pressure [6, 7]. 
This rise in the tissue pressure, together with the exposure to inflammatory mediators 
leads to cell injury and finally pulp necrosis [8].   
 Teeth are subjected to mechanical and thermal stimulation every day. These 
stimuli may cause trauma to the pulp.  Though the pulp has a low compliance 
environment, it also has an inherent plasticity and is capable of repairing and 
regenerating areas of tissue damage [9-12]. In addition to the formation of reparative 
dentin for protection of the pulp from noxious stimuli, the resident stem cells present 
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in the pulp can facilitate regeneration of damaged pulpal tissue. Dental caries is the 
second most common infectious disease of mankind, second only to the common cold 
[13]. It represents the main cause for pulp necrosis. If caries when not identified and 
eliminated in its earliest stage can cause damage to the pulpal tissue due to invasion 
of bacteria into the pulp chamber. Invasion of the dentinal tubules is another pathway 
into the pulp that can be facilitated by trauma, caries, restorative procedures, tooth 
wear and cracks. [14, 15].  Invasion of bacteria and its products in the dentinal tubules 
may cause a decrease in dentin permeability, formation of tertiary dentin or immune 
mediated inflammation [16-19]. The process of pulp necrosis takes place early in part 
because of detection of foreign antigens by pattern recognition receptors (PRRs) 
available on the odontoplastic processes.  Engagement of the innate immune response 
will decrease dentin permeability and stimulate the formation of tertiary dentin. 
Moreover, the detection of foreign antigens activates the resident dendritic cells and 
the inflammatory pathways (NF-κB) [20, 21]. If dental caries is allowed to progress, 
the microbial insult to the pulp will persist leading to an increase in the inflammatory 
infiltrate in the area, vasodilation and edema of the tissues.  During this  process, the 
chronic inflammatory response will increase including both cell-mediated and 
humeral inflammatory infiltrates [22]. The prolonged increase in tissue pressure can 
lead to irreversible damage leading to pulpal necrosis. Once pulpal necrosis is 
initiated in the tissue, it can propagate to include the whole pulpal tissue. As the pulp 
lacks collateral circulation, pulpal necrosis will spread to the apex of the root leading 
to apical periodontitis [23]. 
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3.2. Pulpal and periapical infections 
Pulpal infection has has many interesting features. Miller was a pioneer in 
creating the bacteriological basis for apical infections [24]. His paper titled 
“Microorganisms of the human mouth” was the first paper to suggest the presence of 
bacteria in dental caries and its effect in pulpal and apical destruction [25]. Miller was 
able to identify several species of bacteria in the root canals in necrotic teeth. Then, 
Onderdonk 1901 proved that bacteria are the main etiological factor in pulpal pathosis. 
He was the first to recommend culturing every root canal before obturation [26]. 
 Next came the focal infection theory (1909-1937) in which Rosenow 
suggested that bacteria from the mouth can spread through the blood stream to distant 
organs in the human body causing the spread of infection to these organs [27],  
Hunter in 1911 supported this theory, leading to a consensus that all pulpally infected 
teeth should be extracted, even if they could otherwise be saved by treatment [28, 29]. 
Kakehashi in 1965 [30] demonstrated the importance of the presence of 
infection for the development of the periapical lesions. In his studies, pulp infection 
caused by exposure to the oral environment in conventional rats resulted in the 
development of periapical lesions, whereas, in germ free rats with pulps exposed to 
the oral cavity, no periapical lesions formed.  In addition, in germ free rats, dentin 
bridges were formed, which demonstrated the potential for hard tissue regeneration in 
the absence of infection.  Sundqvist in 1976 [31] also demonstrated the causal 
relationship between periapical lesions and infection. He used the VPI method to 
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study the bacteriology of 32 teeth with intact crowns but necrotic pulps due to trauma. 
Of 32 samples, he was able to isolate bacteria only from those teeth with periapical 
radiolucency. Based on culture results, the prevalence of anaerobic bacteria in 
necrotic canals was 90%. Lesions in patients who experienced symptoms such as pain 
or swelling were found to harbor a greater number of different bacterial strains.  
3.3. Pathogenesis of periapical lesions 
Nair in 2006 defined apical periodontitis as an inflammatory disorder of the 
periradicular tissues caused by persistent microbial infection within the root canal 
system of the affected tooth.  The pathogenesis of periapical lesions is described by 
many authors [32-34]. From a histopathological perspective, the lesions are classified 
according to the distribution of inflammatory cells within the lesion, whether 
epithelial cells are present in the lesion, if the lesion was transferred into a cyst and 
the relationship between cystic cavity and the root canal apex [32]. 
Normal pulp usually contains a few inflammatory cells [2]. When 
microorganisms infect the apical tissues through the apical portion of the root canal, 
acute apical periodontitis is initiated. It is initiated by the neuro-vascular response of 
inflammation, which causes hyperemia, vascular congestion and periodontal ligament 
edema, and leads to extravasation of neutrophils [33]. Upon the multiplication and 
death of Gram-negative bacteria at the apex, organisms can release 
lipopolysaccharides (LPS) [35].  LPS in turn, attracts polymorphonuclear leukocytes 
(PMNLs) to the site of infection –the newly initiated apical periodontitis- by 
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chemotaxis [2].  At this stage, no changes can be observed radiographically as the 
integrity of the periodontium has not been affected yet [33]. When PMNLs are 
attracted to the site of injury, they phagocytose the microorganisms and release both 
leukotrienes, prostaglandins, hydrolytic enzymes and reactive oxygen metabolites. 
Leukotrienes attract more neutrophils and macrophages while macrophages potentiate 
the activation of osteoclasts.  Bone resorption will take place in few days. And the 
periapical radiolucency will be noticeable in the radiographs at this point [36]. LPS 
also activates macrophages to produce chemical mediators such as pro-inflammatory 
cytokines including  interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-
α (TNF-α) and chemotactic interleukin-8 (IL-8) that can contribute to the 
pathogenesis of apical periodontitis. The local effects of IL-1 are boosting the 
adhesion of leukocytes to the endothelial walls, stimulation of lymphocytes, 
potentiation of neutrophil activation, increased production of prostaglandins and 
proteolytic enzymes, enhancement of bone resorption and inhibition of bone 
formation [37].  IL-6 is synthesized by both lymphoid and non-lymphoid cells and its 
synthesis is enhanced by IL-1, TNF-α and interferon-γ (IFN-γ) [38].  IL-6 participates 
in the regulation of the production and control of some IL-1 effects. The presence of 
TNF-α in human apical periodontitis lesions and root canal exudates of the teeth with 
apical periodontitis is reported in several studies [39-41]. IL-8 is a member of the 
chemotactic cytokine family [42]. It is produced by macrophages and fibroblasts 
under the influence of IL-1β and TNF-α. It plays an important role in the acute phase 
of apical periodontitis during massive infiltration of neutrophils. The outcomes of 
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acute primary apical periodontitis could be spontaneous healing –if no infection is 
involved-, expansion of the lesion into bone potentially causing alveolar abscess 
formation or drainage to the oral cavity through sinus tract or transforming to chronic 
apical periodontitis.  
 If the microbial irritation to the periapical tissues persists for extended periods, 
the periapical lesion that is dominated by PMNLs will be occupied by a larger 
number of macrophages, lymphocytes and plasma cells. These cells will be 
encapsulated by collagenous connective tissue. In this stage, the pro-inflammatory 
cytokines derived from macrophages (IL-1, IL-6 and TNFα) act as lymphocyte 
stimulators [33]. T-cells also play a dominant role in down-regulating the lesion in 
this stage. The population of T-cells exceeds B-cells in chronic lesions [43-46], which 
may indicate specific antibacterial reactivity. Two types of T-lymphocytes are present 
in equal amounts are found in this stage. These are T-suppressor cells (Ts) and T-
helper cells (Th) [47-49]. Studies have shown that Th cells aid in the development of 
the periapical lesion while Ts cells play a role in the cessation of the growth of the 
lesion [34, 48]. Th cells play an important role in promoting bone resorption as they 
can stimulate B-cells to produce antibodies. When Th cells are activated, they 
elaborate the cytokine lymphotoxin [50]. Th cells are also capable of producing 
macrophage migration-inhibitory factor (MIF) and gamma interferon [51], they cause 
the activation of macrophages. Macrophages also elaborate the bone resorptive 
monokines IL-1, TNFα and PGE2[34].  Macrophage derived TNFα [52] and T-
lymphocyte derived TNF-β [53] both possess numerous systemic and local effects 
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similar to IL-1. Chronic lesions can remain latent and asymptomatic. During this time, 
radiographic examination will not show any changes in the size of the periapical 
radiolucent area. However, disturbance to this equilibrium by any factor can cause 
microorganisms to proceed into the periapical area leading to a flare-up and 
recurrence of symptoms. Hence, the microorganisms now can be found extra-
radicularly. Rapid enlargement of the periapicial area in the radiographs during this 
stage can also be seen. The term periapical granuloma is used to designate chronic 
apical periodontitis. Periapical granulomas usually enlarge in an irregular manner due 
to the proliferation of the infiltrate cells in all directions. Upon extracting a tooth with 
periapical granuloma, the lesion can be removed in toto during the extraction. This is 
due to the attachment of the fibrous connective tissue capsule, that is formed of 
collagenous fibers, to the root surface [33]. 
 If a periapical granuloma remains untreated, periapical cysts may form as a 
sequel to chronic apical periodontitis. Although all cysts develop from chronic 
granulomas, not all chronic granulomas are transformed to cysts. Two types of cysts 
can be present: a true periapical cyst in which the cystic cavity is completely enclosed 
in epithelial lining, and the periapical pocket cyst in which the cystic cavity is 
connected to the root canal. The latter was also described as a Bay cyst [54, 55].  
3.3.1. Periapical true cyst 
True cyst genesis takes develops in three phases [56].  The first phase is 
represented by the proliferation of the epithelial cell rests. The second phase involves 
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the formation of an epithelium-lined cavity (the cystic cavity). Two theories have 
been proposed to explain development of the cystic cavity: (a) The nutritional 
deficiency theory assumes that the cystic cavity is formed due to necrosis and 
degeneration of the central cells of the epithelial strands from limited sources of 
nutrition. The products of cell degeneration in the necrotic area will attract 
neutrophilic granulocytes. Different micro-activities take place in the necrotic area 
such as epithelial cell degeneration; leukocytic infiltration and tissue exudates 
combine to form the cystic cavity lined with stratified squamous epithelium. The 
second theory for cystic cavity formation is the abscess theory. This theory 
hypothesizes that epithelial cells enclose the exposed connective tissue surfaces and 
the epithelium proliferates to surround the abscess formed by cell lysis. The third 
phase of true cyst genesis is represented by growth of the cystic cavity; however, the 
mechanism of growth is  still not completely defined.  Various theories relate the 
growth of cystic cavity to osmotic pressure [57, 58]. However, the fact that the lumen 
of pocket cyst can also enlarge when it is open to the root canal caused the rejection 
of the osmotic pressure theory [32, 54]. After the formation of a cystic lumen, 
degenerated neutrophils release prostaglandins [59], which in turn, diffuse into the 
surrounding tissues through the porous epithelial wall [56]. The area surrounding the 
epithelium contains numerous T-lymphocytes [60] and macrophages that produce 
inflammatory cytokines. Prostaglandins and inflammatory cytokines cause the 
activation of osteoclasts and lead to bone resorption [33]. 
 8
3.3.2. Periapical pocket cyst 
 The bacteria present in the apical portion of the root canal are assumed to attract 
neutrophils to the apical foramen [32, 54]. Here, a mirco-abscess forms and is in 
contact with the root apex forming an epithelial collar with the epithelial attachment 
[61]. More neutrophils are attracted to the area by chemotaxis due to the existence of 
microbes and their products in the root canal apex. But these attracted neutrophils end 
up in the cystic lumen, which acts as a death trap for the transmigrating neutrophils. 
The sac-like cystic cavity enlarges due to accumulation of the necrotic cells and it 
extends into the periapical area [32, 54]. Enlargement of the pocket cyst and 
associated bone resorption mechanisms are believed to develop similar to the 
periapical true cyst [33].  
 
3.4.The role of anaerobes in periapical infections 
The oral cavity represents a pool of large number of microorganisms. 
Although microorganisms could be bacteria, viruses or fungi, in the oral cavity 
bacteria predominate over other microorganisms. [62].  Likewise, necrotic root canals 
provide an ideal environment for the habitat of oral bacteria. This is facilitated by the 
lack of a host defense since a functional circulation in the canal is lost but may also 
be influenced due to the presence of the porous dentinal tubules in the walls of the 
root canal. The dentinal tubules allow the passage of microorganisms into the dental 
pulp and their colonization [63, 64].  In spite of the presence of hundreds of species of 
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bacteria in the oral cavity, a smaller number of these species could be found in the 
root canals (about 20-30 species only) [65, 66]. The factors affecting the habitat of 
bacteria in the root canals are the temperature, pH, bacterial receptors, type of 
available nutrients, and oxygen tension [67].  
Facultative bacteria are the usual initial colonizers of the root canals. In time, 
oxygen supply decreases as well as the blood supply. Hence, an anaerobic 
environment evolves. Therefore, anaerobic bacteria eventually predominate. 
Anaerobes survive in harsh environments because they are able to produce their 
nutrients from the necrotic pulpal tissue, inflammatory exudates, salivary components 
or the metabolic products of bacteria [68, 69]. 
As we know, anaerobic bacteria colonize the root canal in the form of 
“biofilms”.  Biofilms represent clusters of multiple species of bacteria that “co-
aggregate” to form a complex integrated microbial community.  Ricucci in 2010 
found biofilm arrangements in 77% of the inraradicular root canals studied [70]. The 
presence of bacterial species in biofilms increases their  growth and resistance to 
antimicrobials. It leads to a broader range of growth, more metabolic diversity, less 
competition with other microorganisms, genetic exchange, enhanced pathogenicity 
and symbiotic nutrition [71]. Infected dentinal tubules are present in 70-80% of all 
apical periodontitis lesions [72, 73]. 
The relation between anaerobic microorganisms and inflammation and pain 
attracted considerable attention of scientists. Anaerobes in bacterial biofilms in the 
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root canals may cause neutrophil chemotaxis inhibition, therefore, inhibit 
phagocytosis. They may also be responsible for the increased resistance to antibiotics 
[74, 75] and the production of enzymes and endotoxins [76, 77], which may lead to 
persisting painful periapical lesions [78, 79].  
Anaerobic infections cause necrosis of the pulpal tissue and abscess formation. 
The clinical manifestations to the anaerobic infections are swelling, pain and fever, 
associated with purulent discharge of foul odor related to the bacterial metabolites 
such as ammonia, indoles, urea and amino acids, all of which will stimulate the pulp 
neurons [80]. The significant role of anaerobes in the pathogenesis of periapical 
infections has been confirmed experimentally. In 1981, Moller found several bacterial 
species on pulpal tissues of monkey teeth mechanically exposed for 7 days. These 
teeth were sealed afterwards and examined after 6 months. The bacterial species 
found were α-hemolytic streptococci, enterococci, coliforms and anaerobic bacteria 
such as Bacteroides and eubacteria [81]. Radiographic periapical lesions were found 
in 90% of the teeth. In 1982, Fabricius demonstrated that the ratio between 
anaerobes/aerobes increases with time after sealing the exposed pulp tissue. As the 
ratio was 3.9 at 90 days, it has increased to 11.3 at 1,060 days [82]. In 1986, a study 
by Tronstad used six patients with asymptomatic lesions.  Tronstad was able to gain 
access to the periapical lesion surgically, and revealed the presence of aerobes and 
anaerobes. Porphyromonas gingivalis as well as P. endodontalis were isolated [83]. 
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Most prevalent bacterial species found in the root canals belong to the 
following phyla: Firmicutes (Enterococcus, Eubacterium, Lactobacillius, etc), 
Bacteroidetes (Porphyromonas, Pervotella, Tannerella, etc), Actinobacteria 
(propionibacterium, etc), Fusobacteria (Fusobacterium), Spirochaetes (Terponema, 
etc) [31, 66, 82, 84].  
 
3.5. Porphyromonas gingivalis and its virulence factors 
Black pigmented Gram-negative anaerobic bacteria are frequently found in 
the infected root canals and endodontic abscesses, such as Porphyromonas gingivalis, 
P. endodontalis, Prevotella intermedia and Prevotella nigrescenes [78, 85]. 
Traditional culture and molecular genomic methods were used to confirm the 
presence of those species in the root canals or abscesses [86] [87].   P. gingivalis and 
P. endodontalis in root canals directly correlated with acute symptoms of endodontic 
infections [65, 88]. In addition, P. gingivalis and Fusobacterium nucleatum were 
found to be co-colonizers in biofilms of apical lesions [89]. Recent studies found a 
synergistic relationship between F. nucleatum and P. gingivalis. As the biofilm 
formed by F. nucleatum is enhanced by P. gingivalis, the attachment of P. gingivalis 
to the host cells is enhanced by F. nucleatum [90, 91].   
The species of the genus Porphyromonas usually colonize human and/or 
animal tissues. These species are associated with the oral cavities of humans, dogs, 
cats and non-human primates. Members of the genus Porphyromonas can also be 
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found in warm-blooded animals.  The members of genus Porphyromonas are 0.5-0.8 
by 1.0-3.5 µm in diameter. They are obligate anaerobes, non-spore forming, 
asaccharolytic non-motile rods. They are characterized by the production of a large 
number of enzymes, proteins and end products of their metabolism. All of which are 
active against a broad spectrum of host proteins. They help in the evasion of host 
defenses by hydrolyzing specific host defense compounds include proteinase 
inhibitors, immunoglobulin, iron-containing proteins, bactericidal proteins, 
extracellular matrix proteins and proteins involved in phagocytic functions [92]. 
P. gingivalis produces multiple virulence factors that are capable of promoting 
bone and tissue destruction [93-95].  P. gingivalis may also be critical to the transition 
from gingivitis to periodontitis.   P. gingivalis also interacts with other host 
microbiota to produce destructive compounds leading to the progression of the 
disease [96]. 
Virulence factors are defined as “molecules that result in the establishment 
and maintenance of a species associated with or within the confines of a host.” [96]. 
For the bacteria to be pathogenic, colonization of the host is the first step which can 
be achieved by adherence. Bacterial invasion of the host should transgress the host’s 
external protective tissue barriers and overcome the opposing movement of tissue 
fluids by the host. Finally, the bacteria must find a suitable habitat for its survival. 
Virulence factors may be essential for the process of colonization. They could be 
fimbriae, lipopolysaccharides, exopolysaccharides, outer membrane proteins and 
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outer membrane vesicles. As bacterial species colonize the host tissues in the form of 
biofilms, they produce other factors in the form of antibacterial molecules. These 
molecules help to protect specific bacteria  from competing organisms found within 
the same biofilm [96]. 
3.5.1. The Bacterial Capsule 
Many investigators found the capsule of P. gingivalis to be a very important 
virulence factor. Its main role is antiphagocytic. Several P. gingivalis strains were 
studied by electron microscopy using Ruthenium red staining and routine lead acetate 
staining. This approach showed the presence of an electron dense layer covering the 
outer membrane. This layer is the polysaccharide capsule [97-101]. Encapsulation of 
P. gingivalis is strongly linked to their ability to exhibit decreased autoagglutination 
and become more hydrophilic if compared with the non-capsulated strains [102, 103]. 
The P. gingivalis capsule also increases the resistance to phagocytosis, serum 
resistance and decreased induction of polymorphonuclear leukocyte 
chemiluminescence [102-106]. 
3.5.2. Outer membrane proteins 
Gram  negative bacteria possess a complex double layered cell wall that is due 
to its multilayered cell envelope. The cell envelope is composed of an inner 
cytoplasmic membrane and a thin peptidoglycan layer in the periplasmic space, which 
is surrounded by an asymmetrical outer membrane. The components of the outer 
membrane are: the complex lipopolysaccharide, lipoproteins and peripheral and 
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transport proteins. Transport proteins are the components that connect the outer 
membrane to the peptidoglycans giving the cell envelope its structural integrity. The 
outer cell membrane of Gram  negative bacteria has numerous short fimbriae or if 
motile, long thick flagella. Furthermore, the outer cell membrane contains 
lipopolysaccharides and hemagglutinins. The outer cell membrane contains protein 
complexes.  P. gingivalis has an outer membrane that contains at least 20 major 
proteins ranging in size from 20 to 90 kDa [96, 107].  
Mihara and Holt [108-110] found that a 24-kDa protein of P. gingivalis that 
stimulates thymidine incorporation in human gingival fibroblasts. The purified 24-
kDa protein was named ”fibroblast activating factor” due to its ability to stimulate 
fibroblasts. The same protein was found to function as a cell proliferation factor for 
eukaryotic cells and promotes bone resorption. Watanabe et al. found that the same 
protein promotes polyclonal C cell activation. He also found that the purified 24-kDa 
protein can promote interleukin-1 secretion from mouse peritoneal macrophages 
[111].  
3.5.3. Bacterial fimbriae 
Most Gram  negative bacteria have numerous, thin hair like structures on their 
surface. These structures were first named pili and were believed to be important in 
red blood cell agglutination. Today, these pili are referred to as fimbriae due to their 
thin hair like structure. Fimbriae are composed of two classes: either those involved 
in the adhesion to other bacteria, cells and soft and hard tissues (type specific 
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fimbriae) or are involved in bacterial conjugation (sex pili). The later type is 
characterized by being longer and more flexible compared with the type specific 
fimbriae. The fimbriae usually range in size from 3-25nm in diameter and 3-25µm in 
length. Their distribution may vary as some bacterial species were found to have 10 
fimbriae per cell, other species possess as many as 1000. Except for one or two 
strains, all P. gingivalis strains are found to express fimbriae. They are arranged in a 
peritrichous fashion on the cell surface [97]. The fimbriae of P. gingivalis promote 
binding to the host tissues and saliva coated hydroxyapatite [96].  
3.5.4. Lipopolysaccharide (LPS) 
Lipopolysaccharide is “a major virulence factor” as it exerts a plethora of 
biological effects which result in the amplification of inflammatory reactions” [79].  
From an immunological antibody response, LPS is a non-specific weak antigen and 
antibodies produced against LPS  are typically poor in neutralized its effects. As we 
mentioned before,  LPS is located in the outer membrane of the bacterial cell wall. 
LPS is composed of O-specific polysaccharide, the common core and a lipid 
component referred to as Lipid-A [112]. The most important biological activitiy of 
the bacterial LPS is attributed to Lipid-A [113].  Any slight modification to lipid-A 
leads to a change in the biological effects of LPS such as toxicity, pyrogenecity, 
macrophage activation and complement activation [113, 114]. Lipid-A is composed 
of di-glucosamine, phosphate and fatty acids [115]. Lipid-A structure treatment with 
weak base leads to the release of hydroxy fatty acids from Lipid-A [114, 116]. LPS 
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are large molecules found to have variable molecular weights. The smallest LPS 
reported was found to be larger than 1000 Daltons [117, 118]. 
 Generally, LPS administration causes mast cell degranulation and release of 
histamine and heparin [119]. In addition, LPS causes the release of collagenase from 
host cells [120].  Furthermore, LPS causes the release of tumor necrosis factor from 
macrophages [121].  LPS is capable of inducing fever even if administered in small 
amounts.   Fever is due to the release of interleukin-1 from macrophages. IL-1 in turn 
acts on the hypothalamus, the thermoregulator of the body [122]. LPS promotes the 
adherence of endothelial cells and instigates the release of oxygen radicals, which 
enhances neutrophil mediated injury [123]. In addition, LPS is a non-specific 
stimulator of B-lymphocytes [124, 125]. 
 In chronic periapical lesions associated with microorganism contamination, 
small amounts of LPS can induce a periapical inflammatory response [76, 82]. The 
presence of LPS in necrotic pulps was confirmed experimentally. Both studies of 
Schein and Schilder [126] and Dahlén and Bergenholtz [77] used the limulus lysate 
test to measure LPS. Schein and Schilder found higher levels of LPS in pulpless root 
canals associated with radiographic periapical lesions, more than vital pulp teeth that 
had no radiographic periapical lesions. Dahlén and Bergenholtz revealed a direct 
relationship between the limulus titer and the quantity of Gram negative bacteria 
isolated from infected pulps [79].  
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   LPS, being a causative factor in inducing perapical inflammatory lesions and 
causing more destruction, is a topic explored in several studies. Dwyer and 
Torabinejad [127] were able to initiate the formation of large apical radiolucent areas 
in cat canines when LPS was inoculated into the pulp chamber. However, no 
periapical radiolucencies were found in the teeth pulp chambers inoculated with 
control vehicle (saline of detoxified LPS). Neutrophils dominated in the inflammatory 
exudate. Fewer numbers of lymphocytes and macrophages not typically observed. 
Osteoclasts were observed in areas of bone resorption. Dahlén et al. [128] observed 
periapical bone destruction in 6 of 27 teeth when LPS or oral Fusobacteria was sealed 
for three months in the root canals of monkey molars and premolars. Upon 
histological examination, chronic periapical inflammation together with bone 
resorption was found. Also, there was evidence of elevated enzyme activity by bone 
cells. Warfvinge et al. tested the time intervals required for LPS to produce 
inflammatory lesions in monkeys [129]. Class V cavities were prepared with a dentin 
barrier of less than 1 mm thickness covering the pulp. A paste of lyophilized LPS 
from oral organisms was mixed with saline and placed on the floor of the prepared 
class V cavities and sealed. The teeth were histologically examined after 8 and 72 
hours. Bovine serum albumin was used as a control. While the control samples 
resulted in mild neutrophilic infiltration, the experimental groups showed increased 
leukocytic infiltration from 8 to 72 hours.  
 LPS may have a dominant role in the pathogenesis of peripical bone 
resorption. LPS stimulates the secretion of bone resorbing mediators such as 
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prostaglandin-E2 through Lipid-A moiety [113, 130]. LPS is known to be a stable 
macromolecule that can be shed from the cell wall of some bacteria during their life 
cycles as a result of cell lysis [131]. Hence, LPS is capable of persisting in the root 
canals even after the death of bacteria. Although they (what are you referring to?  The 
bacteria or the LPS persist in small concentrations, they are capable of producing 
inflammatory reactions [113, 132]. LPS is also capable of stimulating osteoclast 
activity and may stimulate other bone cells to secrete pro-inflammatory cytokines 
such as TNF-α and IL-6. These cytokines can also promote bone resorption activity 
[54]. 
 
3.6. Novel Lipids of P. gingivalis 
 Recent studies found that P. gingivalis synthesizes novel complex lipids 
termed phosphorylated dihydroceramide lipids [133, 134]. These phosphorylated 
dihydroceramide lipids include three classes: free non-phosphorylated 
dihydroceramides (DHC), phosphoethanolamine dihydroceramides (PE DHC), and 
phosphoglycerol dihydroceramides (GH DHC). These lipids were found to stimulate 
IL-1β mediated secretion of inflammatory mediators from fibroblasts, such as PGE2. 
They also affect the morphology and adherence of gingival fibroblasts [133, 135]. P. 
gingivalis lipids inhibit osteoblast differentiation by engagement of TLR2 [136]. 
They induce the secretion of monocyte TNF-α. The bacterial lipids have several 
effects such as secretion of inflammatory mediators including PGE2, IL-6 and TNF-α. 
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They also inhibit differentiation of osteoblasts and interfere with their capacity to 
form mineral deposits.  These bacterial lipids also stimulate osteoclastogenesis. They 
were identified from infected root canals which implies that they could be a causative 
factor for apical periodontitis [136]. 
 More recent studies [135, 137] attributed TLR2 activation to 
phosphoethanolamine dihydroceramides. These studies found that the total lipid 
extract of P. gingivalis stimulates mouse dendritic cell activation and suppresses bone 
deposition, which is mediated by osteoblasts via TLR2. A very recent study with 
unpublished data by Clark et al. [138] was able to clarify using advanced HPLC 
separations, that phosphoethanolamine dihydroceramide lipids are not capable of 
activating TLR2 from human cells. Therefore, this study concluded that 
phosophoethanolamine dihydroceramide lipids do not engage TLR2 in mouse 
dendritic cells and the results reported in previous studies could be related to the 
presence of another lipid contamination.  
 In the same study, Clark et al. [138] identified two new serine lipid classes of 
P. gingivalis, Lipid 654 and Lipid 430 classes. These lipids act as ligands for human 
and mouse TLR2. As Lipid 654 contains an ester linked fatty acid whereas Lipid 430 
which is related structurally to Lipid 654 contains only one fatty acid that is amide 
linked to a glycine-serine head group. In addition, Lipid 430 is soluble in aqueous 
solvents where the pH is basic or neutral. However, Lipid 654 class is insoluble, 
except if it is sonicated to form liposome preparations. Based on this study, a new 
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hypothesis can be posited, that is Lipid 654 and Lipid 430 classes of P. gingivalis 
play a dominant role in the pathogenesis of periapical lesions in which bone 
destruction is enhanced and bone formation is inhibited.  
 
3.7. Calcium Hydroxide intracanal medication 
 In root canal treatment, total bacterial elimination by instrumentation is almost 
impossible [84, 139]. Therefore, intracanal medication with calcium hydroxide was 
proposed. Hermann first introduced calcium hydroxide as an intracanal medicament 
in 1920. Nowadays, it is the most widely used intracanal medication in the world. 
Calcium hydroxide has multiple beneficial effects in the field of endodontics. The 
main reason for its use is its antibacterial property [116, 132]. In addition, calcium 
hydroxide is capable of dissolving tissues [140]. Furthermore, its ability to prevent 
root resorption and promote hard tissue formation has encouraged endodontists to use 
it routinely [141, 142]. The antibacterial activity of calcium hydroxide is attributed to 
its high pH resulting from the release of a hydroxyl ions [143]. Calcium hydroxide 
when dissolved in aqueous solvent causes an alkaline pH (about 12.5) [144]. Bacteria 
are usually not capable of surviving such a high pH. Some bacterial strains can 
survive in pH levels ranging from 6 to 9 such as Escherichia coli, Proteus vulgaris, 
Enterobacter aerogenes and Pseudomonas aeroginosa. Other bacterial species can 
tolerate higher pH levels from 9 to11, such as enterococci [145]. On the other hand, 
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Prevotella intermedia, Fusobacterium nucleatum and Porphyromonas gingivalis can 
survive in PH ranging from 8 to 8.3 [143].  
 Apparently, the high pH level of calcium hydroxide causes denaturation of 
bacterial proteins [143]. The ionic bonds maintaining the tertiary structure of the 
proteins break by alkalinization, leading to changes that cause the loss of biological 
activity of these enzymes. On the other hand, the hydroxyl ions released from calcium 
hydroxide are capable of causing damage to the bacterial DNA by splitting of the 
strands causing the destruction of genes [146]. Replication of DNA will be prevented 
accordingly. One of the main strengths of calcium hydroxide is its ability to cause 
damage to the bacterial cytoplasmic membrane by inducing LPS degradation. The 
hydroxyl group reacts with the ester-linked hydroxyl fatty acid, leading to an 
alteration of Lipid-A structure. This alteration in Lipid-A renders the LPS inactive 
[114, 132]. 
 As calcium hydroxide has all of these harmful effects to bacteria, it could be 
thought as being harmful to human tissues as well. However, calcium hydroxide has 
limited solubility and diffusibility, which confines its effects to the root canal 
environment where it is applied, preventing its spread to the periapical tissues –if it is 
not physically extruded beyond the apical foramen [143].  
 Calcium hydroxide is a slow acting medication; it should be applied for 
several days to gain optimal benefit from its usage. Sjögren et al. compared the 
application of calcium hydroxide for 10 minuts versus one week. He found that 10 
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minutes was not sufficient to eliminate bacteria, while placement of calcium 
hydroxide into the root canal for one week resulted in sufficient bacterial elimination 
[147]. However, the exact time needed for calcium hydroxide to gain the best results 
is still not known.  
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4. Hypothesis 
Calcium hydroxide alters the biological activities of bacterial lipids.  
 
5. Aim 
The purpose of this study was to investigate whether treatment of bacterial 
lipid with calcium hydroxide alters its biological action as measured by the mouse 
macrophage cell secretion of TNF-α1.  
6. Study Design 
In this bench top study, mouse macrophages were stimulated with bacterial 
lipids or calcium hydroxide-treated bacterial lipids. The cell culture supernatants were 
analyzed for TNF-α1by ELISA. Cells cultured without tested material served as 
negative controls. Cells cultured with LPS served as positive controls. 
 
 
 
 
 24
6. Materials and Methods 
Bacterial growth, lipid extraction, fractionation and characterization done as 
described in a pervious study. [138]The mouse macrophage cell line RAW 264.7 was 
obtained from American TypeCulture Collection (ATCC, Manassas, Va). Cells were 
grown in Eagle’s minimum essential medium (ATCC) supplemented with 10% fetal 
bovine serum (Hyclone Laboratories Inc, Logan Utah) and 1% antibiotic/antimycotic 
cocktail (300 units/mL penicillin, 300 µg/mL streptomycin, 5 µg/mL amphotericin B 
[Gibco BRL, Gaithersburg, Md]) under standard cell culture conditions (37°C, 100% 
humidity, 95% air, and 5% CO2). 
    Bacterial lipids were purified from P. gingivalis (ATCC 33277, type strain). 
For calcium hydroxide treatment, calcium hydroxide was placed into 50 µg purified 
lipids for 7 days in the incubator. After incubation the lipids were extracted and 
purified again for cell treatment.   
  For cytokine assay, mouse macrophages were seeded into the wells (105 
cells/1 mL medium per well) of 24-well flat-bottom plates (Becton Dickinson, 
Oxnard, Calif).The plates were incubated for 24 hours. Then 5 µg of bacterial lipids 
or calcium hydroxide-treated bacterial lipids were added into each well. After 24-hour 
incubation, culture media were collected and analyzed for TNF-α1 by ELISA (R&D 
Systems, Inc, Minneapolis, Minn). Cells cultured without tested material served as 
negative controls. Cells cultured with LPS served as positive controls. LPS has been 
shown to stimulate mouse macrophages to produce TNF-α1. Therefore, cells treated 
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with 1 µg/mL LPS (Sigma, Saint Louis, Mo) were used as positive controls to make 
sure that the macrophages could be activated and that the ELISA detection method 
worked properly.  
The TNF-α1 difference between treatment and control groups was analyzed 
using one-way analysis of variance (ANOVA).   A p value less than 0.05 is 
considered significant. Post hoc tests were done with Scheffe’s test.  The experiments 
were repeated with two replicates. 
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7. Results 
7.1. The effect of Anti-TLR2 antibody on the stimulation of TNF-
alpha by total lipid and lipid 654 from macrophages 
Compared to the control group, total lipid significantly stimulates the 
production of TNF-alpha (P < 0.01) (Fig. 1). Anti-TLR2 antibody significantly 
reduced the effect of total lipid (P < 0.01) (Fig. 1).  Lipid 654 shows the same effect 
as total lipid to stimulate the production of TNF-alpha (P < 0.01) (Fig. 1).  Anti-TLR2 
antibody also significantly reduced the effect of lipid 654 (P <0.01) (Fig. 1).    
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Figure. 1.  TNF-alpha (ng/ml) production by monocytes when exposed to 
total lipid or lipid 654 extracted from P. gingivalis.  Anti-TLR2 antibody 
significantly reduced the effect of total lipid and lipid 654 for the production 
of TNF-alpha. C, Control. *p < 0.01 versus Control and Total+Ab groups. **p 
< 0.01 versus control and 654+Ab groups. 
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7.2. The effect of calcium hydroxide treatment on total lipid and lipid 
654 for their stimulation of TNF-alpha production from 
macrophages  
Total lipid and lipid 654 significantly promote the release of TNF-alpha from 
macrophages (P < 0.01) (Fig. 2).  Calcium hydroxide treatment significantly reduced 
the effect of total lipid on the release of TNF-alpha (p < 0.01) (Fig. 2). The same 
result was observed when cells were exposed to calcium hydroxide treated lipid 654 
(p < 0.01) (Fig. 2).      
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Figure. 2.  TNF-alpha (ng/ml) production by monocytes when exposed to total lipid,  
lipid 654, calcium hydroxide treated total lipid and lipid 654.  LPS treated cells 
served as a positive control. Cells without treatment served as a negative control. *p < 
0.01 versus Control and Total CH Treated groups. **p < 0.01 versus control and 654 
CH Treated groups. ***p < 0.01 versus control group. 
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8. Discussion 
Our study demonstrated that phosphorylated dihydroceramide lipids of P. 
gingivalis stimulate the release of TNF-α from mouse macrophages via TLR-2. 
Toll-like receptors (TLRs) are “a group of pathogen-associated pattern 
recognition receptors, which have been identified as a key participants in the innate 
recognition of pathogens” [148]. They are considered as trans-membrane receptors. 
TLRs are usually located on the surface of immune cells. Therefore, activation of 
immune cells results in promotion of inflammatory reactions that are stimulated by 
bacterial by-products [149-151]. Bacterial lipoproteins cabable of engaging TLR2 
include lipoproteins, peptidoglycans and Staphylococcus aureas lipoteichoic acid 
[152-154]. On the other hand, TLR4 is the target receptor for LPS [155], which is 
believed to be one of the causative factors of periapical bone resorption. A study by 
Kikuchi et al [151] demonstrated the ability of LPS to induce osteoblast formation by 
stimulating RANKL release from osteoblasts. Both TLR2 and TLR4 are expressed 
from monocytes and macrophages [156].  
Engagement of TLR receptors causes the release of proinflammatory 
cytokines from cells such as IL-1β, IL-6 and TNF-α [153, 157, 158]. Previous 
histological studies were able to link periapical lesions in patients with severe 
periodontal disease with the expression of both TLR2 and TLR4 [159]. Recent 
studies were able to demonstrate that TLR2 is as essential receptor for initiation of 
osteoclastogenesis for P. gingivalis. On the other hand, TLR4 is not necessary for the 
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induction of the same process [148, 160]. They found that TLR2 deficient mice were 
incapable of the production of periapical lesions after their inoculation with P. 
gingivalis.  
Pathological bone loss resulting from  bacterial infections usually takes place 
through the engagement of receptors for pathogen-associated molecular pattern 
(PAMP) molecules. Engagement of TLR2 is also involved with stimulation of 
osteoclasts and/or inhibition of osteoblasts [137]. Bone deposition and secretion of 
bone matrix proteins is mediated by osteoblasts. These proteins include type 1 
collagen, osteocalcin (OC), osteopontin (OPN), bone sialoprotien (BSP) and 
proteoglycans [161]. Osteoblasts are also important in the regulation of 
hydroxyapatite crystal deposition.  
Osteoblasts are regulated by bone morphogenetic proteins that stimulate the 
expression of bone matrix proteins [161]. On the other hand, osteoclasts (large 
multinucleated specialized giant cells) are responsible for bone resorption [136]. They 
differentiate from hemopoietic stem cell lineage of monocytes and macrophages 
[162].  The role of osteoclasts in the process of bone resorption is very significant. A 
member of the tumor necrosis factor (TNF) ligand superfamily, RANKL (Receptor 
activator of nuclear factor κB Ligand) is involved in the production of osteoclasts 
[148]. RANKL exists in two forms, a soluble form and a transmembrane form. They 
both stimulate osteoclast generation if the cells are cultured with macrophage colony-
stimulating factor (M-CSF) [163]. Although some studies found that TNF-α 
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dependent osteoclastogenesis take place in the presence of RANKL [164]. Other 
studies found that osteoclast differentiation stimulated by phosphorylated 
dihydroceramide lipids from P. gingivalis and P. endodontalis takes place 
independently from the classic stimulated RANKL [148, 165]. Also unpublished data 
of a study by Mirucki et al. [165] suggested that phosphorylated dihydroceramide 
lipids of P. endodontalis not only stimulate the release of TNF-α from monocytes via 
TLR2 but also have an inhibitory effect on osteoblast differentiation and affect their 
ability to cause deposition of mineral nodules. The study was able to isolate 
successfully phosphorylated dihydroceramide lipids from P. endodontalis. Although 
this study found analogous phosphorylated ceramide lipids of P. gingivalis, P. 
endodontalis do not possess phosphoglycerol dihydroceramide lipids as does P. 
gingivalis.  
The structure of Lipid 654 (Figure 3) contains two fatty acids: 3-hydroxy iso 
C17:0 is amide linked to glycine and the iso C15:0  is held in ester linkage by a β carbon 
of 3-hydroxy iso C17:0.   the dipeptide head group is composed of glycine and a 
terminal serine.  P. gingivalis also synthesizes another lipid, called Lipid 430, that 
does not contain the esterified iso C15:0 fatty acid.  Lipid 430 also engages TLR2 as 
described below.  Calcium hydroxide treatment of Lipid 654 was demonstrated to 
produce Lipid 654 using mass spectrometric analysis of the calcium hydroxide-
treated Lipid 654.   
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Figure 3: The proposed structure of Lipid 654.  
 Mass spectrometry of Lipid 654  (Figure 4) shows that 654, 640 and 626 
negative ions represent the three constitutive species of the Lipid 654 class.  Also, 
there are no negative ions recovered between 1300 and 1450 indicating that lipid A is 
not present in this lipid preparation. The 690 negative ion is an artifact due to 
recombination of 654 with another chemical moiety.  
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Figure 4: Mass spectrometry of Lipid 654.  Lipid 654 was dissolved in HPLC 
solvent and infused into an ABSciex QTrap 4000 instrument at a flow rate of 100 
ul/ml and used in the negative ion mode.   
Although Lipid 654 shares all the structural characteristics with the previously 
described lipid class termed “Flavolipin”, there are significant differences between 
Lipid 654 and Flavolipin in the biological activity. Flavolipin was named after the 
organisms of the Flavobacterium genus from which it was isolated. Although 
Flavolipin was found to act as a TLR4 ligand, Lipid 654, as well as Lipid 430, do not 
activate via TRL4 but they function as ligands for TLR2 [138]. 
 
     Sodium hypochloride is the most popular irrigant used in the field of 
endodontics. It reacts with unsaturated fatty acids by hydrolysis. It binds to the 
chlorine ion carbon and hydroxyle group, leading to an inactivated, non-virulent 
bacterial by-product. However, phosphorylated dihydroceramide lipids of P. 
gingivalis contain saturated fatty acids that will not react with sodium hypochlorite. 
The absence of the double bonds will not allow the hypochlorous acid molecule to 
react with the lipid molecule. Therefore, using sodium hypochlorite as the only 
irrigant without any adjuvant medication is not sufficient as it may leave some 
amounts of these lipids in the instrumented, irrigated root canals. Consequently, 
healing will not occur [165]. In this study, we evaluated in this study the efficacy of 
calcium hydroxide on these serine lipids. 
 33
  The main reason for performing two-visit non-surgical root canal treatment is 
calcium hydroxide application in the root canals. Although the time needed for 
calcium hydroxide to achieve a proper antibacterial effect is not known. Sjögren  et  al. 
[147] found that application of calcium hydroxide in the root canals for 10 
minutes yielded 50% bacteria free samples while its application for 7 days 
yielded 100% bacteria free samples. When calcium hydroxide was left in the 
canal for one week the bacteria was not able to recover even after five weeks. 
Although many studies found no significant difference in the outcome of non‐
surgical root canal treatment when performed in one or two visits [166‐168]. 
Other studies proved that one visit is not capable of achieving bacteria free 
canals [169, 170]. Therefore, medication with calcium hydroxide is 
recommended. Calcium hydroxide is the most commonly used root canal 
dressing due to its antimicrobial effect [116, 132]. Its antimicrobial activity is 
related to its high pH (12.5), and the release of  a hydroxyl group from its 
molecule. Safavi et al. [132] found that the hydroxyl group reacts with the 
easter‐linked hydroxyl –fatty acid molecule of LPS, leading to alteration of Lipid‐
A. In this study, we found that calcium hydroxide is capable of significant reduction 
on the release of TLR2-dependent TNF-α release from the macrophages by either 
total lipids and Lipid 654 of P. gingivalis. These results are probably explained by the 
calcium hydroxide hydrolysis the ester-linked fatty acid of the Lipid 654 lipid. The 
hydroxyl group of calcium hydroxide acts on the carbonyl group of the lipid 
producing a stable molecule that is unable to be engaged in further reactions.  
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This study demonstrates the role of serine lipids  of P. gingivalis in promoting 
macrophage activation. It also demonstrates the effect of calcium hydroxide on this 
Lipid 654 when exposed to the calcium hydroxide for several days. Based on these 
findings, we now believe that calcium hydroxide use is important as a pulpal 
medicament for disinfection of necrotic pulpal tissues and further support the view 
that endodontic therapy should include two visits of non-surgical root canal treatment.  
 
9. Summary and conclusion:  
1. Total lipids of P. gingivalis stimulate the release of TNF-α from mouse 
macrophages via TLR-2, as well as Lipid 654. 
2. Anti-TLR-2 antibody significantly reduced the effect of total lipids and Lipid 654 
of P. gingivalis.  
3. Treatment of total lipids and Lipid 654 of P. gingivalis with calcium hydroxide 
significantly reduced their effect on the release of TNF-α. 
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